ObsEva SA to present at the LEERINK Partners 7th Annual Global Healthcare Conference February 14th 2018

Wednesday, February 7, 2018 12:01 PM UTC

Geneva, Switzerland and Boston, MA - February 7, 2018 - ObsEva SA (NASDAQ: OBSV), a clinical-stage biopharmaceutical company focused on the development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy, today announced that company management will participate at the LEERINK Partners 7^th Annual Global Healthcare Conference taking place February 14-15^th, 2018, in New York City.

ObsEva's "fireside chat" will be on Wednesday, February 14^th, 2018, at 10:30 a.m. Eastern Time (ET). A webcast will be available in the "Investors" section of ObsEva's website www.ObsEva.com.

About ObsEva

ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving ART outcomes. ObsEva is listed on The NASDAQ Global Select Market and is trading under the ticker symbol "OBSV". For more information, please visit www.ObsEva.com.

###

Media Contact:
Liz Bryan
Spectrum Science
[email protected]
+1 202-955-6222 x2526

Company Contact:

CEO Office contact
Shauna Dillon
[email protected]
+41 22 552 1550

Investor Contact
Mario Corso
Senior Director, Investor Relations
[email protected]
+1 781-366-5726

Attachments:

http://www.globenewswire.com/NewsRoom/AttachmentNg/d4b05304-5075-4a48-a4ef-e8ed86ce2a14

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

ObsEva SA to present at the LEERINK Partners 7th Annual Global Healthcare Conference February 14th 2018

Editor's Picks

Welcome to EconoTimes